Chronic exposure to MPTP as a primate model of progressive parkinsonism: A pilot study with a free radical scavenger

被引:20
作者
Blanchet, PJ
Konitsiotis, S
Hyland, K
Arnold, LA
Pettigrew, KD
Chase, TN
机构
[1] NINDS, Expt Therapeut Branch, NIH, Bethesda, MD 20892 USA
[2] Baylor Univ, Med Ctr, Kimberly H Courtwright & Joseph W Summers Inst Me, Dallas, TX USA
[3] Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX USA
[4] NIMH, Div Epidemiol & Res Serv, NIH, Bethesda, MD 20892 USA
关键词
Parkinson's disease; MPTP; monkeys; neuroprotection; oxidative stress; antioxidant;
D O I
10.1006/exnr.1998.6906
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The development of a validated primate model of progressive parkinsonism is a critical step in the evaluation of drugs that might halt or slow progression of Parkinson's disease, In this pilot study, we gradually exposed 14 cynomolgus monkeys to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP), at a weekly dose of 0.5 mg/kg s.c. for 10 weeks, to determine their probability of not reaching a predetermined endpoint on a disability scale by Kaplan-Meier analysis. Four other MPTP-exposed animals were coadministered the potent free radical scavenger 7-hydroxy-1-[4-(3-methoxyphenyl)-1-piperazinyl]acetylamino-2,2,4,6- tetramethylindan (OPC-14117)as a single oral daily dose of 0.6 g/kg, starting 2 weeks before MPTP initiation. The risk of reaching endpoint by week 10 was 79% and mean time before reaching endpoint was 6 weeks. Global motor activity, recorded in a subset of animals using a portable activity monitor, declined following the first MPTP dose and never recovered. Several cerebrospinal fluid indices of central monoamine metabolism collected by suboccipital puncture at 0, 5, and 10 weeks, including HVA, DOPAC, and tetrahydrobiopterin but not MHPG, were found to be "trait" markers for MPTP exposure, whereas CSF DOPAC and tetrahydrobiopterin constituted potential "state" markers for reaching endpoint, The antioxidant OPC-14117 did not protect against MPTP-induced parkinsonism. Further attempts to validate this incremental model of neurotoxin-induced parkinsonism as a predictor of patient responses to putative neuroprotective agents appear warranted.
引用
收藏
页码:214 / 222
页数:9
相关论文
共 68 条
[1]   BIOCHEMICAL-MECHANISMS OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE TOXICITY - COULD OXIDATIVE STRESS BE INVOLVED IN THE BRAIN [J].
ADAMS, JD ;
ODUNZE, IN .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (08) :1099-1105
[2]   CHRONIC ADMINISTRATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE TO MONKEYS - BEHAVIORAL, MORPHOLOGICAL AND BIOCHEMICAL CORRELATES [J].
ALBANESE, A ;
GRANATA, R ;
GREGORI, B ;
PICCARDI, MP ;
COLOSIMO, C ;
TONALI, P .
NEUROSCIENCE, 1993, 55 (03) :823-832
[3]   MPTP-INDUCED OXIDATIVE STRESS AND NEUROTOXICITY ARE AGE-DEPENDENT - EVIDENCE FROM MEASURES OF REACTIVE OXYGEN SPECIES AND STRIATAL DOPAMINE LEVELS [J].
ALI, SF ;
DAVID, SN ;
NEWPORT, GD ;
CADET, JL ;
SLIKKER, W .
SYNAPSE, 1994, 18 (01) :27-34
[4]  
Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25
[5]  
[Anonymous], 1996, Ann Neurol, V40, P99
[6]  
BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
[7]   ACETYL-LEVO-CARNITINE PROTECTS AGAINST MPTP-INDUCED PARKINSONISM IN PRIMATES [J].
BODISWOLLNER, I ;
CHUNG, E ;
GHILARDI, MF ;
GLOVER, A ;
ONOFRJ, M ;
PASIK, P ;
SAMSON, Y .
JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1991, 3 (01) :63-72
[8]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[9]   THE CLINICAL SYNDROME OF STRIATAL DOPAMINE DEFICIENCY - PARKINSONISM INDUCED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) [J].
BURNS, RS ;
LEWITT, PA ;
EBERT, MH ;
PAKKENBERG, H ;
KOPIN, IJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (22) :1418-1421
[10]   RAPID ATP LOSS CAUSED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE IN MOUSE-BRAIN [J].
CHAN, P ;
DELANNEY, LE ;
IRWIN, I ;
LANGSTON, JW ;
DIMONTE, D .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (01) :348-351